Yuyu Pharma Inc Capital Reinvestment Ratio
Yuyu Pharma Inc capital reinvestment ratio. Yuyu Pharma Inc (000227) has a Capital Reinvestment Ratio of 1.75x as of September 2025, meaning it reinvests 2% of its operating cash flow (₩836.62 Million) in capital expenditures (₩1.46 Billion). See Yuyu Pharma Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Yuyu Pharma Inc (2014–2024)
Capital reinvestment ratio of Yuyu Pharma Inc from 2014 to 2024. This chart tracks Yuyu Pharma Inc's Capital Reinvestment Ratio across 8 annual periods. See financial agility of Yuyu Pharma Inc to measure the company's free cash flow as a share of total liabilities.
Yuyu Pharma Inc Capital Reinvestment Ratio by Year (2014–2024)
Yuyu Pharma Inc capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see cash efficiency ratio of Yuyu Pharma Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.6% |
| 2023 | 12.13x | ₩420.86 Million | ₩5.11 Billion | ▲ +800.7% |
| 2021 | 1.35x | ₩4.51 Billion | ₩6.07 Billion | ▲ +120.5% |
| 2019 | 0.61x | ₩13.19 Billion | ₩8.06 Billion | ▼ -61.8% |
| 2018 | 1.60x | ₩6.11 Billion | ₩9.76 Billion | ▼ -82.7% |
| 2017 | 9.25x | ₩561.35 Million | ₩5.19 Billion | ▲ +3819.4% |
| 2016 | 0.24x | ₩9.82 Billion | ₩2.32 Billion | ▼ -20.4% |
| 2014 | 0.30x | ₩1.36 Billion | ₩404.37 Million | — |